Copyright
©The Author(s) 2024.
World J Clin Oncol. Oct 24, 2024; 15(10): 1293-1308
Published online Oct 24, 2024. doi: 10.5306/wjco.v15.i10.1293
Published online Oct 24, 2024. doi: 10.5306/wjco.v15.i10.1293
Table 1 Sequence list of polymerase chain reaction primers
Primer name | Upstream primer sequence (5’-3’) | Downstream primer sequences (5’-3’) |
AKT1 | GCTCAGCCCACCCTTCAAG | GCTGTCATCTTGGTCAGGTGGT |
PIK3CA | TAGTGTCCGGGAAAATGGCT | GGCATGCTCTTCGATCACAG |
EGFR | GCCAAGGCACGAGTAACAAGC | GGGCAATGAGGACATAACCAGC |
BCL2 | AGACGGAAGAGAAATTCACTGG | GCCATAATCTCATCAGGGG |
IL6 | GTAGTGAGGTTCAAG | GCTGTCATCTTGGTCAGGTGGT |
GAPDH | GAAGGTCGGAGTCAACGGAT | CCTGGAAGATGGTGATGGG |
Table 2 Comparison of body weight, tumor volume, tumor weight, and tumor inhibition rate of nude mouse
Group | Number | Weight/g | Tumor volume/mm3 | Tumor weight/g | Anti-tumor rate (%) |
Control | 3 | 18.83 ± 0.15 | |||
Model | 3 | 15.133 ± 0.40b | 1641.48 ± 499.84 | 1.25 ± 0.13 | |
Capecitabine | 3 | 17.633 ± 0.06b | 616.98 ± 156.00a | 0.56 ± 0.15b | 62.41 |
BXD-L | 3 | 16.833 ± 0.06b | 726.37 ± 168.48a | 0.77 ± 0.08b | 55.75 |
BXD-M | 3 | 17.673 ± 0.15b | 541.85 ± 95.72a | 0.51 ± 0.09b | 66.99 |
BXD-H | 3 | 17 ± 0.1b | 682.00 ± 281.61a | 0.55 ± 0.13b | 58.48 |
Table 3 IC50 screening and cell proliferation assay of Cell Counting Kit-8 for the detection of banxia xiexin decoction in MGC803
Group | 24 hours OD | Proliferation rate (%) | 48 hours OD | Proliferation rate (%) |
Control | 1.88 ± 0.02 | 2.73 ± 0.04 | ||
10% BXD | 1.85 ± 0.01 | 98 | 2.36 ± 0.06b | 86.09 |
20% BXD | 0.91 ± 0.07b | 45.78 | 1.53 ± 0.02b | 54.62 |
40% BXD | 0.48 ± 0.01b | 21.18 | 0.54 ± 0.02b | 17.09 |
Capecitabine | 1.00 ± 0.06b | 50.48 | 1.65 ± 0.19b | 59.11 |
LY294002 | 1.00 ± 0.01b | 50.25 | 1.00 ± 0.07b | 34.7 |
BXD + LY294002 | 0.64 ± 0.04b | 30.07 | 0.77 ± 0.05b | 26.05 |
Table 4 mRNA expression content in the phosphoinositide 3-kinase/protein kinase B signaling pathway (mean ± SD)
Group | EGFR | PIK3CA | AKT1 | IL6 | BCL2 |
Model | 1.00 ± 0.1 | 0.80 ± 0.25 | 1.01 ± 0.11 | 1.56 ± 0.06 | 2.23 ± 0.52 |
Capecitabine | 0.97 ± 0.4 | 0.34 ± 0.17a | 0.07 ± 0.04b | 1.01 ± 0.14b | 0.52 ± 0.13b |
BXD | 0.79 ± 0.39a | 0.41 ± 0.18 | 0.04 ± 0.01b | 1.52 ± 0.25 | 1.09 ± 0.56a |
LY294002 | 0.25 ± 0.14b | 0.07 ± 0.02b | 0.09 ± 0.05b | 1.59 ± 0.17 | 0.85 ± 0.47a |
BXD + LY294002 | 0.01 ± 0.01b | 0.38 ± 0.21 | 0.06 ± 0.01b | 0.74 ± 0.07b | 0.40 ± 0.11b |
- Citation: Zu GX, Sun KY, Liu XJ, Tang JQ, Huang HL, Han T. Banxia xiexin decoction prevents the development of gastric cancer. World J Clin Oncol 2024; 15(10): 1293-1308
- URL: https://www.wjgnet.com/2218-4333/full/v15/i10/1293.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i10.1293